what is the main difference between semaglutide and tirzepatide vs Semaglutide: What's Difference? — Ryn Journal Semaglutide vs Tirzepatide for Weight

Abstract Several peptide dual agonists of the human glucagon receptor (GCGR) and the glucagon-like peptide-1 receptor (GLP-1R) are in development for the treatment of type 2 diabetes, obesity and their associated complications

Cauda equina syndrome: If you experience sudden onset of bowel or bladder dysfunction, bilateral leg weakness, or saddle anesthesia (numbness in the groin and inner thighs), this is a surgical emergency

The price, the side effects, insurance changing its mind, plain old life

While this class of medications is generally considered safe and effective, potentially severe neurological complications may be associated with rapid weight loss and nutritional deficiencies following GLP-1 agonist use

The most prevalent cardiovascular complication of T2DM is related to atherosclerosis and its complications, such as acute myocardial infarction, stroke, and peripheral artery disease, which are responsible for high mortality and morbidity among T2DM patients

Causes include immune thrombocytopenic purpura (ITP), certain medications, viral infections, and bone marrow disorders